SEC Form 4 · accession 0001274644-17-000016
Ocera Therapeutics, Inc. · OCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Byrnes
Officer — CFO and Treasurer
Period of report
Mar 28, 2017
Accepted (ET)
Mar 28, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 28, 2017 | P | 3,000 | $1.2848 | A | 13,000 | D |
Table II — derivative securities
No Table II lines on this filing.